Andrade, DM, Tai, P, Dalmau, J et al (2011) Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis?
Neurology, 76: 1355–7.
Antoine, JC, Honnorat, J, Anterion, CT et al (1995) Limbic encephalitis and immunological perturbations in two patients with thymoma. Journal of Neurology, Neurosurgery and Psychiatry, 58: 706–10.
Armangue, T, Titulaer, MJ, Málaga, I et al (2013) Pediatric anti-N-methyl-D-aspartate receptor encephalitis: clinical analysis and novel findings in a series of 20 patients. Journal of Pediatrics, 162: 850–6.
Baldridge, EB, Bessen, HA (1990) Phencyclidine. Emergency Medicine Clinics of North America, 8: 541–50.
Braakman, HM, Moers-Hornikx, VM, Arts, BM et al (2010) Pearls & oysters: electroconvulsive therapy in anti-NMDA receptor encephalitis. Neurology, 75: e44–6.
Brain, WR, Henson, RA (1958) Neurological symptoms associated with carcinoma. Lancet, 2: 971–5.
Brain, WR, Adams, RD (1965) Epilogue: a guide to the classification and investigation of neurological disorders associated with neoplasms. In The Remote Effects of Cancer on the Nervous System (eds Brain, WR, Norris, FH) Grune & Stratton.
Buckley, C, Oger, J, Clover, L et al (2001) Potassium channel antibodies in two patients with reversible limbic encephalitis. Annals of Neurology, 50: 73–8.
Chapman, MR, Vause, HE (2011) Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. American Journal of Psychiatry, 168: 245–51.
Correll, CM (2013) Antibodies in epilepsy. Current Neurology and Neuroscience Reports, 13: 348.
Corsellis, JA, Goldberg, GJ, Norton, AR (1968) ‘Limbic encephalitis’ and its association with carcinoma. Brain, 91: 481–96.
Creten, C, Van der Zwaan, S, Blankespoor, RJ et al (2011) Late onset autism and anti-NMDA-receptor encephalitis. Lancet, 378: 98.
Dalmau, J, Tuzun, E, Wu, HY et al (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Annals of Neurology, 61: 25–36.
Dalmau, J, Gleichman, AJ, Hughes, EG et al (2008) Anti-NMDA-receptor encephalitis: case series and an analysis of the effects of antibodies. Lancet Neurology, 7: 1091–8.
Dalmau, J, Lancaster, E, Martinez-Hernandez, E et al (2011) Clinical experience and laboratory investigations in patients with anti-NMDR encephalitis. Lancet Neurology, 10: 63–74.
Dropcho, EJ (1989) The remote effects of cancer on the nervous system. Neurologic Clinics, 7: 579–603.
Granerod, J, Ambrose, HE, Davies, NW et al (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infectious Diseases, 10: 835–44.
Graus, F, Cordon-Cardo, C, Posner, JB (1985) Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology, 35: 538–43.
Graus, F, Boronat, A, Xifro, X et al (2010) The expanding clinical profile of anti-AMPA receptor encephalitis. Neurology, 74: 857–9.
Haussleiter, IS, Emons, B, Schaub, M et al (2012) Investigation of antibodies against synaptic proteins in a cross-sectional cohort of psychotic patients. Schizophrenia Research, 140: 258–9.
Irani, SR, Buckley, C, Vincent, A et al (2008) Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology, 71: 1647–8.
Irani, SR, Alexander, S, Waters, P et al (2010a) Antibodies to KV1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain, 133: 2734–48.
Irani, SR, Bera, K, Waters, P et al (2010b) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain, 133: 1655–67.
Irani, SR, Michell, AW, Lang, B et al (2011) Faciobrachial dystonic seizures precede lgI1 antibody limbic encephalitis. Annals of Neurology, 69: 892–900.
Kayser, MS, Dalmau, J (2011) The emerging link between autoimmune disorders and neuropsychiatric disease. Journal of Neuropsychiatry and Clinical Neurosciences, 23: 90–7.
Kayser, MS, Titulaer, MJ, Gresa-Arribas, N et al (2013) Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-D-aspartate receptor encephalitis. JAMA Neurology, 70: 1133–9.
Lai, M, Huijbers, MG, Lancaster, E et al (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurology, 9: 776–85.
Lancaster, E, Lai, M, Peng, X et al (2010) Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurology, 9: 67–76.
Mackay, G, Ahmad, K, Stone, J et al (2012) NMDA receptor autoantibodies in sporadic Creutzfeldtt-Jakob disease. Journal of Neurology, 259: 1979–81.
Masdeu, JC, Gonzalez-Pinto, A, Matute, C et al (2012) Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia. American Journal of Psychiatry, 169: 1120–1.
Newsom-Davis, J (1997) Autoimmune neuromyotonia (Isaacs' syndrome): an antibody-mediated potassium channelopathy. Annals of the New York Academy of Sciences, 835: 111–9.
Prüss, H, Dalmau, J, Harms, L et al (2010) Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology, 75: 1735–9.
Prüss, H, Finke, C, Holtje, M et al (2012) N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Annals of Neurology, 72: 902–11.
Rhoads, J, Guirgis, H, McKnight, C et al (2011) Lack of anti-NMDA receptor autoantibodies in the serum of subjects with schizophrenia. Schizophrenia Research, 129: 213–4.
Rogers, D (1992) Motor Disorder in Psychiatry: Towards a Neurological Perspective. John Wiley & Sons.
Saiz, A, Blanco, Y, Sabater, L et al (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain, 131: 2553–63.
Schmitt, SE, Pargeon, K, Frechette, ES et al (2012) Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology, 79: 1094–100.
Steiner, J, Walter, M, Glanz, W et al (2013) Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry, 70: 271–8.
Titulaer, MJ, Soffietti, R, Dalmau, J et al (2011) Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. European Journal of Neurology, 18: 19–e3.
Titulaer, MJ, McCracken, L, Gabilondo, I et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurology, 12: 157–65.
Tsutsui, K, Kanbayashi, T, Tanaka, K et al (2012) Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features. BMC Psychiatry, 12: 37.
Vincent, A, Lang, B, Kleopa, KA (2003) Autoimmune channelopathies and related neurological disorders. Neuron, 52: 123–38.
Vincent, A, Buckley, C, Schott, JM et al (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy responsive form of limbic encephalitis. Brain, 127: 701–12.
Voltz, R, Gultekin, SH, Rosenfeld, MR et al (1999) A serological marker of paraneoplastic limbic and brain stem encephalitis in patients with testicular cancer. New England Journal of Medicine, 340: 1788–95.
Zandi, MS, Irani, SR, Lang, B et al (2011) Disease-relevant autoantibodies in first episode schizophrenia. Journal of Neurology, 258: 686–8.